Provider

Customers can also act as a sponsor, purchasing tests for key workers and vulnerable people

The HIMSS Media team gives a recap of recent headlines surrounding the FDA, COVID-19 and new digital health software products.

Also: Providence supporting COVID-19 patients at home with Xealth and Twistle; Lief Therapeutics incorporates DrChrono's Open API.

Users can choose from 100 conditions and get information about telemedicine pricing and medication services. 

The new website and app were born out of a partnership with Apple, the CDC, the White House Coronavirus Task Force and FEMA.

Both efforts are employing popular consumer wearables and health trackers to spot potential cases of COVID-19 or other viral diseases as they begin.

Dr. Yuri Maricich, chief medical officer at Pear Therapeutics, speaks on his company's experience bringing a digital therapeutic product through the regulator's experimental program for health software.

Deep Dive: Barriers to care can be traced to SDOH, and technology has a role to play as the best solution that connects data between providers and the community.

Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces. 

Yesterday MassChallenge hosted a summit on innovation in the age of the coronavirus crisis, and panelists discussed how providers are implementing new digital programs into their toolbox.